These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The risk of MDR-TB and polyresistant tuberculosis among the civilian population of Tomsk city, Siberia, 1999. Kimerling ME; Slavuckij A; Chavers S; Peremtin GG; Tonkel T; Sirotkina O; Golubchikova V; Baddeley A Int J Tuberc Lung Dis; 2003 Sep; 7(9):866-72. PubMed ID: 12971671 [TBL] [Abstract][Full Text] [Related]
4. Development of extensively drug-resistant tuberculosis during multidrug-resistant tuberculosis treatment. Shin SS; Keshavjee S; Gelmanova IY; Atwood S; Franke MF; Mishustin SP; Strelis AK; Andreev YG; Pasechnikov AD; Barnashov A; Tonkel TP; Cohen T Am J Respir Crit Care Med; 2010 Aug; 182(3):426-32. PubMed ID: 20413630 [TBL] [Abstract][Full Text] [Related]
5. Alcohol use and the management of multidrug-resistant tuberculosis in Tomsk, Russian Federation. Miller AC; Gelmanova IY; Keshavjee S; Atwood S; Yanova G; Mishustin S; Furin JJ; Shin SS Int J Tuberc Lung Dis; 2012 Jul; 16(7):891-6. PubMed ID: 22507895 [TBL] [Abstract][Full Text] [Related]
6. Patient Characteristics Associated with Tuberculosis Treatment Default: A Cohort Study in a High-Incidence Area of Lima, Peru. Lackey B; Seas C; Van der Stuyft P; Otero L PLoS One; 2015; 10(6):e0128541. PubMed ID: 26046766 [TBL] [Abstract][Full Text] [Related]
7. 'Sputnik': a programmatic approach to improve tuberculosis treatment adherence and outcome among defaulters. Gelmanova IY; Taran DV; Mishustin SP; Golubkov AA; Solovyova AV; Keshavjee S Int J Tuberc Lung Dis; 2011 Oct; 15(10):1373-9. PubMed ID: 22283898 [TBL] [Abstract][Full Text] [Related]
8. Integrated Management of Physician-delivered Alcohol Care for Tuberculosis Patients: Design and Implementation. Greenfield SF; Shields A; Connery HS; Livchits V; Yanov SA; Lastimoso CS; Strelis AK; Mishustin SP; Fitzmaurice G; Mathew TA; Shin S Alcohol Clin Exp Res; 2010 Feb; 34(2):317-30. PubMed ID: 19930235 [TBL] [Abstract][Full Text] [Related]
9. Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries. Espinal MA; Kim SJ; Suarez PG; Kam KM; Khomenko AG; Migliori GB; Baéz J; Kochi A; Dye C; Raviglione MC JAMA; 2000 May; 283(19):2537-45. PubMed ID: 10815117 [TBL] [Abstract][Full Text] [Related]
10. Factors associated with culture conversion among adults treated for pulmonary extensively drug-resistant tuberculosis during 2018-2019 in the Russian Federation: an observational cohort study. Russkikh A; Korotych O; Sereda Y; Samoilova A; Achar J; Yedilbayev A; Dara M; Vasilyeva I Monaldi Arch Chest Dis; 2021 Jan; 91(1):. PubMed ID: 33470087 [TBL] [Abstract][Full Text] [Related]
11. Knowledge, attitudes, and practices of physicians in Tomsk Oblast tuberculosis services regarding alcohol use among tuberculosis patients in Tomsk, Russia. Mathew TA; Shields AL; Imasheva A; Shin SS; Mishustin SP; Peremitin GG; Strelis AK; Yanova GV; Greenfield SF; Furin JJ Cult Med Psychiatry; 2009 Dec; 33(4):523-37. PubMed ID: 19768525 [TBL] [Abstract][Full Text] [Related]
12. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations. API Consensus Expert Committee J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350 [TBL] [Abstract][Full Text] [Related]
14. Undertreated HIV and drug-resistant tuberculosis at a referral hospital in Irkutsk, Siberia. Heysell SK; Ogarkov OB; Zhdanova S; Zorkaltseva E; Shugaeva S; Gratz J; Vitko S; Savilov ED; Koshcheyev ME; Houpt ER Int J Tuberc Lung Dis; 2016 Feb; 20(2):187-92. PubMed ID: 26792470 [TBL] [Abstract][Full Text] [Related]
15. Factors contributing to the high prevalence of multidrug-resistant tuberculosis among previously treated patients: a case-control study from China. Wang K; Chen S; Wang X; Zhong J; Wang X; Huai P; Wu L; Wang L; Jiang S; Li J; Peng Y; Yao H; Ma W Microb Drug Resist; 2014 Aug; 20(4):294-300. PubMed ID: 24328894 [TBL] [Abstract][Full Text] [Related]
16. Predictor of multidrug resistant tuberculosis in southwestern part of Ethiopia: a case control study. Gobena D; Ameya G; Haile K; Abreha G; Worku Y; Debela T Ann Clin Microbiol Antimicrob; 2018 Jul; 17(1):30. PubMed ID: 29970076 [TBL] [Abstract][Full Text] [Related]
17. Comparison of the effectiveness of WHO short-course chemotherapy and standard Russian antituberculous regimens in Tomsk, western Siberia. Mawer C; Ignatenko N; Wares D; Strelis A; Golubchikova V; Yanova G; Lyagoshina T; Sharaburova O; Banatvala N Lancet; 2001 Aug; 358(9280):445-9. PubMed ID: 11513907 [TBL] [Abstract][Full Text] [Related]
18. Outcomes and follow-up of patients treated for multidrug-resistant tuberculosis in Orel, Russia, 2002-2005. Cavanaugh JS; Kazennyy BY; Nguyen ML; Kiryanova EV; Vitek E; Khorosheva TM; Nemtsova E; Cegielski JP Int J Tuberc Lung Dis; 2012 Aug; 16(8):1069-74. PubMed ID: 22691694 [TBL] [Abstract][Full Text] [Related]
19. Social support and incentives programme for patients with tuberculosis: experience from the Russian Federation. Jakubowiak WM; Bogorodskaya EM; Borisov SE; Danilova ID; Lomakina OB; Kourbatova EV Int J Tuberc Lung Dis; 2007 Nov; 11(11):1210-5. PubMed ID: 17958983 [TBL] [Abstract][Full Text] [Related]
20. Predictors of unsuccessful interim treatment outcomes of multidrug resistant tuberculosis patients. Atif M; Bashir A; Ahmad N; Fatima RK; Saba S; Scahill S BMC Infect Dis; 2017 Sep; 17(1):655. PubMed ID: 28962599 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]